{
    "nct_id": "NCT03333655",
    "official_title": "A Multicenter Study to Explore the Mechanism of Acquired Immune Escape In Patients With Metastatic Cancer Progressing on Checkpoint Inhibitor Therapy",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Response assessment of complete response (CR), partial response (PR), or long-term stable disease (SD) for \\>6 months with a cancer immunotherapy treatment for metastatic cancer or hematologic malignancies either through a marketed CPI or through participation in a Roche/Genentech CPI clinical trial.\n* Availability of tissue sample.\n\nExclusion Criteria:\n\n* Pregnant, lactating, or intending to become pregnant during the study.\n* Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial.\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Response assessment of complete response (CR), partial response (PR), or long-term stable disease (SD) for >6 months with a cancer immunotherapy treatment for metastatic cancer or hematologic malignancies either through a marketed CPI or through participation in a Roche/Genentech CPI clinical trial.\n* Availability of tissue sample.",
        "exclusion": "* Pregnant, lactating, or intending to become pregnant during the study.\n* Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial."
    }
}